Lobbying Relationship

Client

Teva Pharmaceuticals USA, Inc.

More records

Lobbying firm

Holland & Knight, LLP

More records

  • Drug pricing.
  • Drug Pricing.

Duration: to

General Issues: Medicare/Medicaid, Pharmacy, Health Issues

Spending: about $30,000 (But it's complicated. Here's why.)

Agencies lobbied since 2019: U.S. Senate, House of Representatives

Related Foreign Entities: Teva Pharmaceutical Instustries LTD (Petach Tikva, ISR); contribution to lobbying: $0; ownership 100%

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Paul Bock Chief of Staff, Sen. Herb Kohl; Counsel, Senate Judiciary Committee
Kathryn Lehman Special Assistant to Speaker of the House; Policy Director, House Majority Whip; Director of Coalition Outreach, Speaker of House; Chief of Staff, House Republican Conference
Michael Werner n/a
Micheal Werner n/a

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Q1 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page